We are live on
!
Find out more
PCM
Palouse Capital Management Portfolio holdings
AUM
$160M
1-Year Est. Return
36.15%
This Fund
S&P 500
This Quarter
Est. Return
+2.71%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$286M
AUM Growth
-$9.11M
(-3.1%)
Cap. Flow
-$15.6M
Cap. Flow
% of AUM
-5.45%
Top 10 Holdings %
Top 10 Hldgs %
25.93%
Holding
116
New
14
Increased
46
Reduced
45
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco
IVZ
|
+$8.43M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$6.91M |
| 3 |
Molson Coors Class B
TAP
|
+$4.98M |
| 4 |
NXP Semiconductors
NXPI
|
+$2.09M |
| 5 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$745K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$8.31M |
| 2 |
Eaton
ETN
|
+$6.34M |
| 3 |
Amgen
AMGN
|
+$6.25M |
| 4 |
Welltower
WELL
|
+$4.79M |
| 5 |
Target
TGT
|
+$4.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.13% |
| 4 | Industrials | 9.71% |
| 5 | Consumer Discretionary | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Thor Industries
THO
$4.04B
| $223K | 0.08% |
2,659
+191
| +8% | +$18.3K |
|
102
Vishay Intertechnology
VSH
$5.03B
| $215K | 0.08% |
+10,541
| New | +$248K |
|
|
UCB
103
United Community Banks
UCB
$4.3B
| $214K | 0.07% |
7,679
+602
| +9% | +$18.2K |
|
104
Ingredion
INGR
$6.49B
| $211K | 0.07% |
2,012
+137
| +7% | +$14K |
|
105
AMN Healthcare
AMN
$1.19B
| $200K | 0.07% |
+3,665
| New | +$210K |
|
|
UCTT
106
Ultra Clean Holdings
UCTT
$3.76B
| $128K | 0.04% |
+10,209
| New | +$148K |
|
|
107
Amgen
AMGN
$219B
| – | – |
-33,865
| Closed | -$6.25M |
|
|
108
Eaton
ETN
$174B
| – | – |
-84,773
| Closed | -$6.34M |
|
109
Helen of Troy
HELE
$671M
| – | – |
-2,727
| Closed | -$268K |
|
|
110
Pfizer
PFE
$149B
| – | – |
-241,538
| Closed | -$8.31M |
|
|
SCS
111
DELISTED
Steelcase
SCS
| – | – |
-77,084
| Closed | -$1.04M |
|
112
Scansource
SCSC
$1.16B
| – | – |
-5,075
| Closed | -$205K |
|
|
113
Target
TGT
$66.8B
| – | – |
-57,657
| Closed | -$4.39M |
|
114
Gentherm
THRM
$1.24B
| – | – |
-8,238
| Closed | -$324K |
|
|
115
Welltower
WELL
$170B
| – | – |
-76,392
| Closed | -$4.79M |
|
|
CBM
116
DELISTED
Cambrex Corporation
CBM
| – | – |
-5,896
| Closed | -$308K |
|
Similar funds
PCC
CF
SGCM
RCWM
LCA
WHCI
FPWM
SMF
Palouse Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Palouse Capital Management held 116 positions worth $286M, down 3.1% from $295M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Palouse Capital Management withdrew a net $15.6M in Q3 2018, closing 10 positions and reducing 45 holdings. Its most notable exit was Pfizer, an estimated $8.31M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Palouse Capital Management opened a new position in Invesco worth $7.72M.
- Palouse Capital Management's largest Q3 2018 buy was Invesco: 337,299 shares worth $7.72M.
- Palouse Capital Management added most to Molson Coors Class B in Q3 2018, an estimated $4.98M increase.
- Palouse Capital Management's biggest Q3 2018 reduction was Nucor, cutting an estimated $3.25M.
- Palouse Capital Management fully exited Pfizer in Q3 2018, selling an estimated $8.31M.
- Palouse Capital Management's ten largest holdings make up 26% of its $286M portfolio in Q3 2018.
- Palouse Capital Management opened 14 new positions and closed 10 in Q3 2018.
- Palouse Capital Management's portfolio value fell 3.1% quarter-over-quarter to $286M.
Based on Palouse Capital Management's 13F filing for Q3 2018, filed 29 Oct 2018.